Premium
Proteomic analysis of Brucella abortus cell envelope and identification of immunogenic candidate proteins for vaccine development
Author(s) -
Connolly Joseph P.,
Comerci Diego,
Alefantis Timothy G.,
Walz Alexander,
Quan Marian,
Chafin Ryan,
Grewal Paul,
Mujer Cesar V.,
Ugalde Rodolfo A.,
DelVecchio Vito G.
Publication year - 2006
Publication title -
proteomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.26
H-Index - 167
eISSN - 1615-9861
pISSN - 1615-9853
DOI - 10.1002/pmic.200500730
Subject(s) - biology , virology , groel , brucella , chaperonin , microbiology and biotechnology , western blot , antiserum , antigen , brucellosis , biochemistry , immunology , gene , escherichia coli
Brucella abortus is the etiologic agent of bovine brucellosis and causes a chronic disease in humans known as undulant fever. In livestock the disease is characterized by abortion and sterility. Live, attenuated vaccines such as S19 and RB51 have been used to control the spread of the disease in animals; however, they are considered unsafe for human use and they induce abortion in pregnant cattle. For the development of a safer and equally efficacious vaccine, immunoproteomics was utilized to identify novel candidate proteins from B. abortus cell envelope (CE). A total of 163 proteins were identified using 2‐DE with MALDI‐TOF MS and LC‐MS/MS. Some of the major protein components include outer‐membrane protein (OMP) 25, OMP31, Omp2b porin, and 60 kDa chaperonin GroEL. 2‐DE Western blot analyses probed with antiserum from bovine and a human patient infected with Brucella identified several new immunogenic proteins such as fumarate reductase flavoprotein subunit, F0F1‐type ATP synthase α subunit, and cysteine synthase A. The elucidation of the immunome of B. abortus CE identified a number of candidate proteins for developing vaccines against Brucella infection in bovine and humans.